- Home
- ARCT
as 02-21-2025 4:00pm EST
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | SAN DIEGO |
| Market Cap: | 444.5M | IPO Year: | N/A |
| Target Price: | $63.60 | AVG Volume (30 days): | 428.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $14.30 - $45.00 | Next Earning Date: | 03-06-2025 |
| Revenue: | $160,399,000 | Revenue Growth: | -45.85% |
| Revenue Growth (this year): | 6.54% | Revenue Growth (next year): | 0.25% |
Latest Arcturus Therapeutics Holdings Inc. News
ARCT Breaking Stock News: Dive into ARCT Ticker-Specific Updates for Smart Investing
Simply Wall St.
5 days ago
High Growth Tech Stocks In The United States To Watch
MT Newswires
8 days ago
Arcturus Therapeutics Says EU Commission Approves COVID-19 Vaccine Kostaive
PR Newswire
8 days ago
European Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 Vaccine
Zacks
11 days ago
Axsome (AXSM) Surges 20.2%: Is This an Indication of Further Gains?
MT Newswires
18 days ago
Arcturus Therapeutics Appoints Moncef Slaoui Chair Designate
Business Wire
18 days ago
Arcturus Therapeutics Announces Appointment of Moncef Slaoui, Ph.D., as Chair Designate
Business Wire
22 days ago
Meiji Seika Pharma Receives Approval for Adding Domestic Manufacturing Sites in Japan for KOSTAIVE®, a Self-amplifying mRNA Vaccine Against COVID-19
Business Wire
23 days ago
Arcturus Therapeutics to Present at Guggenheim Securities SMID Cap Biotech Conference
Compare ARCT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ARCT Arcturus Therapeutics Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.